Clinical Trial Update: Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sildenafil for dyskinesias in Parkinson's disease was terminated. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sildenafil (Viagra) (sildenafil)

Snippet

Sponsor: Loma Linda University | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED | Results posted: 2014-07-22